Clik here to view.
Nobel Laureate Zinkernagel Delivers Keynote Speech at NCKU
TAINAN, Taiwan National Cheng Kung University (NCKU) hosted the 2013 International Symposium on Infectious Disease and Signal Transduction together with the 2013 Taiwan-Japan Joint Symposium on Cell...
View ArticleClik here to view.
Wright Medical Group, Inc. Provides Date of MicroPort Shareholder Meeting to...
ARLINGTON, Tenn. Wright Medical Group, Inc. (NASDAQ: WMGI) today reported it has been advised by MicroPort Scientific Corporation (HK: 0853) that the Hong Kong Stock Exchange has granted clearance...
View ArticleClik here to view.
DiagCor to Launch Natera’s Panorama™ Non-Invasive Prenatal Test in Hong Kong
SAN CARLOS, Calif. Natera today announced that DiagCor, a manufacturer of in-vitro diagnostic products and service provider of clinical diagnostic tests, has signed an agreement to launch Natera’s...
View ArticleClik here to view.
Evangelist Nick Vujicic’s World Outreach Reaches 400 Million; Web Documentary...
Smart Multimedia Gallery As part of his World Outreach tour, evangelist Nick Vujicic met with a little girl in Phnom Penh, Cambodia, in May 2013 with whom he shared more than a few similarities....
View ArticleClik here to view.
Biogen Idec and Samsung Bioepis Announce Agreement to Market Anti-TNF...
CAMBRIDGE, Mass. & SEOUL, Korea Biogen Idec (NASDAQ: BIIB) and Samsung Bioepis today announced that through their joint venture, Biogen Idec has exercised its right to enter into an agreement to...
View ArticleClik here to view.
Innate Immunotherapeutics Completes $10M IPO
SYDNEY Innate Immunotherapeutics is pleased to announce it has successfully raised A$10 million through its Initial Public Offer (IPO) and will immediately commence planning its clinical trial for...
View ArticleClik here to view.
Roche and Genentech Acquire Unlimited Access to Open Monoclonal Technology’s...
PALO ALTO, Calif. Open Monoclonal Technology, Inc. (OMT), an innovator in transgenic research for discovery of human therapeutic antibodies, today announced that Genentech, a member of the Roche...
View ArticleClik here to view.
pSivida Corp. Reports FDA Labeling Discussions for ILUVIEN® for DME; Advisory...
WATERTOWN, Mass. pSivida Corp. (NASDAQ: PSDV) (ASX: PVA), a leader in the development of sustained release, drug delivery products for treating eye diseases, today announced that its licensee...
View ArticleClik here to view.
BeiGene Enrolls First Patient in Phase 1 Study of BGB-283
BEIJING BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an...
View ArticleClik here to view.
Blaze Bioscience Announces Initiation of First-in-Human Phase 1 Clinical...
SEATTLE & MELBOURNE, Australia Blaze Bioscience, Inc. and its subsidiary, Blaze Bioscience Australia Pty Ltd, today announced the initiation of the first Phase 1 clinical study of the first...
View ArticleClik here to view.
World’s First MEVION S250 Proton Therapy Treatment Delivered at Barnes-Jewish...
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
DxTerity’s REDI-Dx Wins 2013 NCT CBRNe Product of the Year Award
LOS ANGELES DxTerity Diagnostics announced that REDI-Dx™, the company’s blood-based gene expression test for estimating individualized levels of radiation exposure,* was named the 2013 NCT CBRNe...
View ArticleClik here to view.
CARMAT的生物假体人工心脏首次植入人体
巴黎 (美国商业资讯) –CARMAT (Paris:ALCAR) (FR0010907956, ALCAR)是世界上最先进的全人工心脏课题的设计者和开发者, 为罹患终末期心力衰竭的人士提供另一种医疗选择。该公司宣布，依据ANSM（法国卫生部国家药品及保健产品安全署）和个人保护委员会（伦理委员会）颁发的批复，公司的人工心脏已在一项可行性研究中首次植入人体。...
View ArticleClik here to view.
世界初のMEVION S250による陽子線治療をバーンズ・ジューイッシュ病院で実施
Smart Multimedia Gallery View of the MEVION S250 Proton Therapy System treatment room at the Siteman Cancer Center at Barnes-Jewish Hospital in St. Louis, MO. (Photo: Business Wire) View and Share...
View ArticleClik here to view.
Menicon, Azabu University, and Yokohama City University Identify the Glaucoma...
NAGOYA, Japan Menicon announces that an article entitled, “Dogs and humans share a common susceptibility gene SRBD1 for glaucoma risk”, which presents the results of a study conducted by Menicon,...
View ArticleClik here to view.
カルマトのバイオプロテーゼ人工心臓を初めてヒトに移植
パリ （ビジネスワイヤ） — 世界最先端の完全人工心臓プロジェクトを設計・開発し、末期心不全を患う人々に代替法を提供しているカルマト（Paris:ALCAR）（FR0010907956,...
View ArticleClik here to view.
Menicon、麻布大学和横滨市立大学发现犬类青光眼易感基因SRBD1
日本名古屋 (美国商业资讯)–Menicon宣布，一篇题为“犬类的青光眼风险易感基因SRBD1与人类相同”的论文已发表于科学期刊PLoS ONE，该论文呈报了Menicon、麻布大学和横滨市立大学开展的一项研究（以下称“该研究”）的结果。 Menicon与麻布大学和横滨市立大学合作开展的研究发现，日本柴犬的青光眼易感基因与人类相同。...
View ArticleClik here to view.
radioACTIVE inc. Releases “Sectional Walker”, an Interactive CT and MRI...
TOKYO radioACTIVE inc. has brought an ultimate solution to CT / MRI cross-sectional anatomy for iOS users. While touch tablets made things convenient and portable, learning anatomy is not an...
View ArticleClik here to view.
Navidea Biopharmaceuticals Expands Lymphoseek® Global Commercialization Efforts
DUBLIN, Ohio Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today it has entered into a distribution...
View ArticleClik here to view.
Allergan, Inc. and Medytox, Inc. Complete Licensing Agreement
IRVINE, Calif. & SEOUL, South Korea Allergan, Inc., (NYSE: AGN) and Medytox, Inc. today announced that they have closed the license agreement which was previously announced on September 25,...
View Article